Sofwave MedicalSOFWF 48 PB Ratio is 16.51 as of Jun. 30, 2026, which is 110% above its 10-year median of 7.85. GuruFocus rates SOFWF with a GF Score™ of 48/100 and a GF Value™ of $11.23 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Sofwave Medical ranks worse than 94.78% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-30), Sofwave Medical's share price is $16.00. Sofwave Medical's Book Value per Share for the quarter that ended in Mar. 2026 was $0.97. Hence, Sofwave Medical's PB Ratio of today is 16.51.
The historical rank and industry rank for Sofwave Medical's PB Ratio or its related term are showing as below:
SOFWF'
s PB Ratio Range Over the Past 10 Years
Min: 2.31 Med: 7.85 Max: 16.46
Current: 14.07
During the past 8 years, Sofwave Medical's highest PB Ratio was 16.46. The lowest was 2.31. And the median was 7.85.
SOFWF's PB Ratio is ranked worse than 94.78% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2.085
vs SOFWF: 14.07
During the past 12 months, Sofwave Medical's average Book Value Per Share Growth Rate was 40.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -1.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 44.10% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Sofwave Medical was 158.40% per year. The lowest was -20.10% per year. And the median was 48.30% per year.
Back to Basics: PB Ratio
Sofwave Medical (OTCPK:SOFWF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Sofwave Medical PB Ratio Related Terms
Sofwave Medical PB Ratio Historical Data
* Premium members only.
The historical data trend for Sofwave Medical's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Sofwave Medical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sofwave Medical PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sofwave Medical's PB Ratio distribution charts can be found below:
* The bar in red indicates where Sofwave Medical's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Sofwave Medical's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Sofwave Medical (SOFWF) has a PB Ratio of 16.51 as of Jun. 30, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sofwave Medical and its competitors. This is 110% above median its historical median of 7.85. Over the past decade, Sofwave Medical's PB Ratio has ranged from 2.31 to 16.46. According to the industry distribution chart, Sofwave Medical ranks #745 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 94.8%.
Is Sofwave Medical's PB Ratio too high?
Sofwave Medical's current PB Ratio of 16.51 is 110% above median its 10-year median of 7.85. Over the past 10 years, this metric has ranged from a low of 2.31 to a high of 16.46. The Medical Devices & Instruments industry median PB Ratio is 2.09. Sofwave Medical's value of 16.51 is 691.8% above this industry median. Based on the distribution chart, Sofwave Medical ranks #745 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sofwave Medical has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sofwave Medical's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sofwave Medical ranks #745 out of 786 companies for PB Ratio. This places Sofwave Medical in the lower half of its industry. The industry median PB Ratio is 2.09. Sofwave Medical's value of 16.51 is 691.8% above this benchmark. Historically, Sofwave Medical's own PB Ratio has ranged from 2.31 to 16.46 over the past decade. While the company's 10-year median is 7.85 vs. the industry median of 2.09, Sofwave Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.09, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sofwave Medical's current PB Ratio of 16.51 is 691.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sofwave Medical and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sofwave Medical's current PB Ratio is 16.51, which is 110% above median its own 10-year median of 7.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sofwave Medical stock overvalued right now?
Based on GuruFocus' analysis, Sofwave Medical (SOFWF) is currently considered Significantly Overvalued. The stock's GF Value™ is $11.23, compared to a current price of $16.00 — trading 42.5% above its estimated fair value. The current PB Ratio is 16.51, which is 110% above median its 10-year median of 7.85 and 691.8% above the Medical Devices & Instruments industry median of 2.09. Sofwave Medical's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Sofwave Medical (SOFWF), the current PB Ratio is 16.51 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sofwave Medical (SOFWF) Overvalued in 2026?
Based on GuruFocus' analysis, Sofwave Medical stock appears to be overvalued.
The current stock price of $16.00 is trading 42.5% above its estimated GF Value™ of $11.23.
GuruFocus considers Sofwave Medical to be Significantly Overvalued.
Key valuation signals for SOFWF:
PB Ratio: 16.51 (110% above median its 10-year median of 7.85)
GF Value™: $11.23 vs. price of $16.00 (42.5% above fair value)
Industry Position: 691.8% above the Medical Devices & Instruments median (#745 of 786)
No single metric tells the full story. See the SOFWF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SOFWF has been successfully added to your 
